Oligonucleotide Therapeutics Society

Antisense Oligonucleotide Therapy in Chronic Hepatitis B: Clinical Progress and Phase 3 Outcomes

September 7th, 2026|Categories: Featured Perspectives On Current Science|

When Sheree was 26, she kept wondering why she was always so tired. Though she was a mom and a nurse working multiple double shifts, she was still young and knew she shouldn’t be this fatigued. Then the nausea and abdominal pain began. Soon, the ...

Al3Cas12f RKK: A New, Enhanced Compact Editor that is Highly Efficient

August 27th, 2026|Categories: Featured Perspectives On Current Science|

CRISPR-based gene-editing tools have transformed the biomedical field, but delivering these systems directly into human tissues — known as in vivo gene editing — remains a major challenge. Many therapeutic CRISPR approaches still rely on ex vivo editing, where the patient’s cells are removed, ...

Go to Top